RedC Biotech Ltd. is a revolutionary startup aiming to solve the critical issue of blood transfusions. Its slogan "RedC is developing an industrial process to produce universal red blood cells for life-saving transfusions and therapies" summarizes its mission. The company, founded in 2015 and headquartered in Israel, offers a proprietary solution for universal red blood cells, eliminating the need for donors and seasonal shortages. RedC's universal red blood cells have several advantages, including being pathogen-free, having no undesirable blood components, and being suitable for almost every patient. This innovation has the potential to save countless lives worldwide and promises to provide access and availability when and where needed. Despite the lack of disclosed last investment details, RedC Biotech Ltd. presents a compelling and impactful investment opportunity in the biotech industry.
There is no investment information
No recent news or press coverage available for RedC Biotech Ltd..